News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Myeloma Paper of the Day, September 3rd, Suggested by Robert Orlowski
Robert Orlowski/mdanderson.org
Sep 3, 2025, 11:22

Myeloma Paper of the Day, September 3rd, Suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Predicting prognosis of AL cardiac amyloidosis by MRI and deep learning shows a C-Index of 0.91 & AUC of 0.95 in predicting 2.6-year survival (HR: 2.67), thus outperforming the Mayo model (C-Index=0.65, AUC=0.71).”

Title: Medullary breast cancer and germline BRCA1 mutations: a possible criterion for genetic testing

Authors: Adriana I. Apostol, David Lim, Steven A. Narod

You can read the Full Article in Hereditary Cancer in Clinical Practice.

Myeloma Paper of the Day

More posts featuring Robert Orlowski on OncoDaily.

cancer Myeloma Myeloma Paper of the Day OncoDaily Oncology Robert Orlowski
Special Coverage
Voices
Sep 5, 2025, 10:18
Isabel Mestres: I Recently Contributed with an Op-Ed to Resolve Global Health’s New Report
Dialogues
Sep 5, 2025, 10:12
MASCC 2025 Presidential Training Fellowship Spotlight: Celia Díez de los Ríos de la Serna
Voices
Sep 5, 2025, 10:11
Staying Physically Active Isn't Just Personal Care: It's Professional Responsibility - American Cancer Society
Voices
Sep 5, 2025, 09:55
Florian Lordick: Chemoresistance of Novel Therapeutic Approaches for Esophageal Adenocarcinoma
Science
Sep 5, 2025, 09:41
Vivek Subbiah: How Aggressive Brain Tumors Exploit Glucose to Suppress Normal Activity
Voices
Sep 5, 2025, 08:57
Honoring a Life of Compassion and Impact - CancerWorld
Voices
Sep 5, 2025, 08:57
C/Can Advances Breast Imaging Training for Global Cities
FDA Approvals
Sep 5, 2025, 08:44
Olomorasib Receives FDA Breakthrough Therapy Designation for KRAS G12C-Mutant NSCLC
Voices
Sep 5, 2025, 08:36
Miriam Mutebi: Scalpel-Wielding Surgeon is Terrified of Needles - Especially When They’re Aimed at Me
Dialogues
Sep 5, 2025, 08:09
ONCOFFEE: Gabriela Inés Villanueva – From Argentina to the US and Back, Shaping Pediatric Oncology
Dialogues
Sep 5, 2025, 08:07
Roche’s CMO Levi Garraway on Personal Journey, Developing Foundation Medicine, and Cancer Research
Dialogues
Sep 5, 2025, 08:05
What Happens When Cancer Meets a Global Pandemic? | Patient stories